• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and breastfeeding is challenging for women with the condition. There is a lack of information about how long-term exposure to these medications can affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that further high-quality research is needed.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication must consider the benefits of taking it against the possible risks to the foetus. Doctors don't have enough data to give clear advice, but can provide information about risks and benefits to aid pregnant women in making an informed decision.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during early pregnancy were not at higher risk of fetal malformations or structural birth defects. Researchers used a large population-based study of case control to assess the frequency of structural defects that were major in infants who were born to mothers who were taking stimulants during pregnancy. Pediatric cardiologists and clinical geneticists reviewed the cases to ensure accurate case classification and to minimize the chance of bias.

However, the researchers' study had its limitations. The researchers were not able in the beginning, to separate the effects of the medication from the disorder. This makes it difficult for researchers to determine if the small associations observed among the groups exposed were due to medication use or affected by the presence of comorbidities. Additionally, the researchers did not examine the long-term outcomes of offspring.

The study did find that infants whose mothers had taken adhd treatment medication medication during pregnancy were at a slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had taken off their medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who were taking stimulant adhd depression medication medication during pregnancy were also at an increased risk of having a caesarean section or having a baby with low Apgar score (less than 7). These increases appeared to be independent of the type of medication taken during pregnancy.

The researchers suggest that the low risk associated with the use of ADHD medications during early pregnancy may be offset by the higher benefit for both mother and child from continued treatment for the woman's condition. Physicians should discuss this with their patients and, if possible, assist them in developing strategies for improving their coping skills which can reduce the impact of her disorder on her daily life and relationships.

Interactions with Medication

As more women than ever are being diagnosed with ADHD and treated with medication, the question of whether to keep or discontinue treatment during pregnancy is one that more and more doctors face. Most of the time, these decisions are made in the absence of any evidence that is clear and definitive regardless, so doctors must weigh what they know about their experiences, the experiences of other doctors, and what medications are prescribed For adhd research suggests on the subject and their own judgments for each individual patient.

In particular, the issue of potential risks to the baby can be a challenge. The research on this subject is based on observation instead of controlled studies and a lot of the results are in conflict. The majority of studies restrict their analysis to live births, which may underestimate the severity of teratogenic effects that can lead to abortions or terminations of pregnancy. The study discussed in the journal club addresses these shortcomings by analyzing both the data from deceased and live births.

Conclusion: While some studies have shown an association between ADHD medications and certain birth defects, other studies have not established a link. The majority of studies show a neutral, or even somewhat negative, impact. In all cases, a careful evaluation of the potential risks and benefits should be conducted.

It isn't easy, but not impossible for women with ADHD to stop taking their medication. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can lead to depression and feelings of isolation. Additionally, the loss of medication can interfere with the ability to do job-related tasks and drive safely that are crucial aspects of a normal life for many people with ADHD.

She recommends women who are uncertain about whether to keep or stop medication in light of their pregnancy, consider educating family members, friends and colleagues on the condition, its effects on daily functioning, and on the advantages of continuing the current treatment regimen. Educating them can also aid in ensuring that the woman feels supported when she is struggling with her decision. Some medications can pass through the placenta. If the patient decides to stop taking her ADHD medication while pregnant and breastfeeding, it is important to be aware that the medication could be passed on to her infant.

Risk of Birth Defects

As the use and misuse of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases as does the concern about the potential effects of these drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge on this topic. Researchers utilized two massive data sets to examine over 4.3 million pregnant women and determine if stimulant medication use increased birth defects. While the overall risk is low, the researchers did find that first-trimester exposure to ADHD medications was linked to an increase in the risk of certain heart defects like ventriculo-septal defects (VSD).

The authors of the study did not discover any link between the use of early medications and other congenital anomalies, like facial deformities or club feet. The results are in line with previous studies revealing a small but significant increase in the risk of heart malformations in women who started taking ADHD medications prior to pregnancy. The risk was higher during the latter part of pregnancy, when a lot of women begin to discontinue their ADHD medications.

Women who were taking ADHD medication during the first trimester were more likely need a caesarean and also have a low Apgar after delivery, and have a baby who needed help breathing after birth. The researchers of the study were not able to remove bias in selection since they restricted the study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope that their research will provide doctors with information when they see pregnant women. The researchers suggest that while discussing risks and benefits are crucial, the decision regarding whether or not to stop taking medication should be according to the severity of each woman's ADHD symptoms and her requirements.

The authors also caution that even though stopping the medication is an alternative, it is not an option that is recommended due to the high rate of depression and other mental health problems in women who are pregnant or recently post-partum. Further, research shows that women who stop taking their medications will have a tough time adjusting to a life without them once the baby is born.

Nursing

The responsibilities of being a new mom can be overwhelming. Women who suffer from ADHD are often faced with a number of difficulties when they must deal with their symptoms, go to doctor appointments, prepare for the birth of a child and adjust to a new routine. Many women decide to continue taking their ADHD medication during pregnancy.

The risk to nursing infant is low because the majority of stimulant medication passes through breast milk at low levels. The amount of exposure to medications will vary based on the dosage and frequency of administration as well as the time of day. In addition, individual medications enter the baby's system differently through the gastrointestinal tract as well as breast milk. The impact of this on a newborn isn't fully known.

Due to the absence of research, some doctors may recommend stopping stimulant drugs during a woman's pregnancy. This is a difficult decision for the patient, who must weigh the benefit of continuing her medication against the possible dangers to the foetus. In the meantime, until more information is available, doctors should inquire with all pregnant patients about their experience with ADHD and whether they are taking or planning to take medication during the perinatal time.

A increasing number of studies have shown that most effective adhd medication women can safely continue taking their ADHD medication while they are pregnant and nursing. In the end, many patients opt to do this and in consultation with their doctor they have discovered that the benefits of continuing their current medication exceed any risk.

It's important for women with ADHD who are contemplating breastfeeding to seek out a specialist psychiatrist's guidance prior to becoming pregnant. They should discuss the medication they are taking with their physician as well as the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation is also required to help pregnant people with ADHD understand their symptoms and underlying disorder and learn about treatment options and reinforce existing strategies for coping. This should involve a multidisciplinary approach with the GP doctors, obstetricians and psychiatrists. Pregnancy counseling should include discussion of a treatment plan for the mother as well as the child, as well as monitoring for indicators of deterioration, and, if needed, adjustments to the medication regimen.